Afficher la notice abrégée

dc.creatorKyriakoulis K.G., Kollias A., Kyriakoulis I.G., Kyprianou I.A., Papachrysostomou C., Makaronis P., Kotronias R.A., Terentes-Printzios D., Toskas I., Mikhailidis D.P.en
dc.date.accessioned2023-01-31T08:47:45Z
dc.date.available2023-01-31T08:47:45Z
dc.date.issued2022
dc.identifier10.2174/1570161119666210824160332
dc.identifier.issn15701611
dc.identifier.urihttp://hdl.handle.net/11615/75578
dc.description.abstractBackground: Venous Thromboembolism (VTE) is common among patients with severe Coronavirus Disease 2019 (COVID-19). Anticoagulation in hospitalized COVID-19 patients has been associated with survival benefit; however, the optimal thromboprophylaxis strategy has not yet been defined. Objective: To identify published guidance reports by national and international societies regarding thromboprophylaxis strategies in COVID-19 patients in different settings (outpatients, hospitalized, post-discharge). Methods: A systematic review of the literature (Pubmed/EMBASE) was conducted independently by two investigators. Results: Among 1942 initially identified articles, 33 guidance documents were included: 20 published by national and 13 by international societies. These documents provide recommendations mainly for hospitalized (97% of reports) and post-discharge (75%) COVID-19 patients, and less so for outpatients (34%). Thrombotic and bleeding risk stratification prior to any treatment decision is the cornerstone of all suggested thromboprophylaxis strategies; 81% of the documents recommend thromboprophylaxis for all hospitalized patients with a prophylactic dosage of low molecular weight heparin irrespective of VTE risk. Intermediate or therapeutic dose intensity is recommended in high VTE risk patients by 56% and 28% of documents, respectively. Mechanical thromboprophylaxis is suggested in case of high bleeding risk or contraindication to pharmacological thromboprophylaxis (59% of documents). Extended pharmacological thromboprophylaxis is recommended for patients with high VTE risk after hospital discharge (63% of documents). For non-hospitalized outpatients, 28% of documents recommend pharmacological thromboprophylaxis for high VTE risk. Conclusion: The current guidance identifies thromboprophylaxis in COVID-19 patients, especially during hospitalization, as of major importance for the prevention of VTE. Recommendations are derived from limited evidence from observational studies. © 2022 Bentham Science Publishers.en
dc.language.isoenen
dc.sourceCurrent Vascular Pharmacologyen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85123646960&doi=10.2174%2f1570161119666210824160332&partnerID=40&md5=0b02073219ab45d18925906947379cf6
dc.subjectadult respiratory distress syndromeen
dc.subjectanticoagulant therapyen
dc.subjectartificial ventilationen
dc.subjectasthmaen
dc.subjectatrial fibrillationen
dc.subjectbleedingen
dc.subjectcardiovascular mortalityen
dc.subjectcoronavirus disease 2019en
dc.subjectcreatinine clearanceen
dc.subjectdeep vein thrombosisen
dc.subjectdyspneaen
dc.subjectextracorporeal oxygenationen
dc.subjectgenetic polymorphismen
dc.subjecthospital dischargeen
dc.subjecthospital mortalityen
dc.subjecthospitalizationen
dc.subjecthumanen
dc.subjectintensive care uniten
dc.subjectlung embolismen
dc.subjectobesityen
dc.subjectplatelet counten
dc.subjectReviewen
dc.subjectrisk assessmenten
dc.subjectsystematic reviewen
dc.subjectthrombocyte activationen
dc.subjectthrombocytopeniaen
dc.subjectthrombosis preventionen
dc.subjectvenous thromboembolismen
dc.subjectaftercareen
dc.subjectrisk factoren
dc.subjectvenous thromboembolismen
dc.subjectanticoagulant agenten
dc.subjectAftercareen
dc.subjectAnticoagulantsen
dc.subjectCOVID-19en
dc.subjectHumansen
dc.subjectPatient Dischargeen
dc.subjectRisk Factorsen
dc.subjectSARS-CoV-2en
dc.subjectVenous Thromboembolismen
dc.subjectBentham Science Publishersen
dc.titleThromboprophylaxis in Patients with COVID-19: Systematic Review of National and International Clinical Guidance Reportsen
dc.typeotheren


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée